Further, the MYC expression is positively associated with AXL, EIF4E, and EMT signatures (Supplementary Fig. 4H) and both mRNA and protein levels of the EIF4E are of prognostic significance in KRAS-mutant lung cancer, lung adenocarcinoma, and lung cancer (Fig. 2k; Supplementary Fig. 5A–C). This evidence concerns the gene MYC and lung adenocarcinoma.